Welcome to the website of the Office of Professional and Occupational Regulation, an agency within the Department of Professional and Financial Regulation. We appreciate your visit to our site, and we look forward to assisting you.
You may follow this link to the Secretary of State's office to view a list of board members. Members of the public should not contact board members with questions or comments. All questions, comments or any other board-related matters can be directed pharmacy.lic@maine.gov 207-624-8651.
Purpose
The Board of Pharmacy was established to protect the public through the regulation of pharmacies and pharmacists in Maine.
The primary responsibilities of the Board are to examine and license qualified applicants for licensure in the categories of Pharmacists or Pharmacists Assistants; to regulate and control the sale, character and standards of all drugs, poisons or medicines; to inspect during business hours all apothecaries, dispensaries, and locations where pharmaceuticals are manufactured, stored, distributed, compounded, dispersed or retailed; to secure samples of drugs and cause them to be analyzed and to keep a record of all persons examined and registered. The Board also investigates complaints against licensees and takes appropriate disciplinary action.
Notice of Proposed Agency Rulemaking
To view full text of notice please click here: Board of Pharmacy Proposed Rulemaking (Centralized Pharmacy Services)
The Maine Board of Pharmacy is proposing changes to four chapters of its rules:
Chapter 1, Definitions (Amend)
Chapter 20-A, Self-Service Customer Kiosks (Amend)
Chapter 21, Centralized Pharmacy Services (Repeal and Replace current Chapter 21, Central Prescription Processing)
Chapter 24, Retention of Records by Pharmacies (Amend)
The proposed rulemaking will amend the Board’s rules regarding centralized pharmacy services. The proposed rules set forth requirements when multiple entities work together to perform centralized pharmacy services, which includes all activities, functions, obligations and responsibilities required by Board rules in connection with the processing, filling, refilling, or dispensing of a prescription drug order.
Comments on the proposed rulemaking may be submitted in writing: (1) by e-mail to Kristin Racine at kristin.racine@maine.gov or (2) by mail to the Maine Board of Pharmacy, 35 State House Station, Augusta, ME 04333-0035, no later than 5:00 p.m. EST on Friday, January 16, 2026.
Are You a Mandated Reporter?
Maine law requires that medical, mental health and social services personnel immediately report or cause a report to be made to the Maine Department of Health and Human Services (DHHS) when the provider knows or has reasonable cause to suspect that an incapacitated or dependent adult has been or is likely to be abused or neglected or that a suspicious incapacitated or dependent adult death has occurred.
Notice Regarding License Verification Requests
License verifications is available at no charge by visiting Board of Pharmacy online licensing portal. OPOR does not issue paper license verifications.
Future correspondence from the Board of Pharmacy will be sent to you by email, so please be sure to keep your contact information current. Follow this link to verify your contact information.
Press Release – Maine CDC Issues Standing Order Expanding Access to COVID-19 Vaccine – 9/12/2025
Board Statement
2023
#01-2023 Statement of the Maine Board of Pharmacy on Whether Rulemaking is Required Before Pharmacists are Permitted to Administer Vaccines Consistent with Public Law 2023 Chapter 170
Law amended 32 M.R.S. 13831-Authority for Pharmacists to Administer Vaccines. Informational for licensees and interested parties as prepared by Board Staff.
2022
Current Important Notices/Reminders
Compliance with Board Records Request 4-10-2023 (PDF) - THIS NOTICE IS FOR EDUCATIONAL PURPOSES
Laws/Statutory
Laws enacted by the 131st Legislature, 1st Regular and 1st Special Session
Please visit the Maine Legislature website for information on the effective date of laws enacted http://legislature.maine.gov
- Prescribing, Dispensing and Administering HIV Prevention Drugs, Ch. 43- Effective 5-6-2025
- Public Law Chapter 245 (LD899) An Act to Authorize Vaccine Administration by Pharmacy Technicians and Reduce Vaccine Administration Training Requirements for Pharmacists (Emergency)
- Public Law 2023 Chapter 170 (LD1151) An Act Concerning the Authority for Pharmacists to Administer Vaccines (Emergency)
- Public Law 2023 Chapter 115 (LD351) An Act to Increase Access to Birth Control by Making Certain Contraception Accessible from a Pharmacist
- Public Law 2023 Chapter 329 (LD1615) An Act Regarding Limits on Medication in Vending Machines
- OTP Repeal Ch. 36-Amend Ch1-13-25 Adopted-Effective 11-4-2023
Advisory Rulings
Older Important Notices/Reminders
- FAQ's Regarding Manufacturers and Opioid Medication Fee Assessment and Product Registration (PDF)
- FAQ's Regarding Manufacturers and Insulin Product Registration Fee (PDF)
- Urgent and Important Message - Manufacturers of Opioid Medication and Opioid Product Registration (PDF)
- Message from Attorney General Janet T. Mills on heroin and opioid abuse in Maine (PDF)
- Policy statement regarding licensure of Retail Suppliers of Prescription Medical Devices (PDF)
- ME Board of Pharmacy Statement of Concern on Personal Importation of Prescription Drugs from International Mail Order Prescription Pharmacies (PDF)
- Memorandum-Clinical Laboratory Improvement Amendments (CLIA) Program (April 5, 2013) (PDF)
- Memorandum-Compounding for Office Use (April 5, 2013) (PDF)
- Guidance Notice 4/10/2012 (PDF) - rule and law change affecting pharmacy interns.